310 related articles for article (PubMed ID: 26777297)
1. Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis.
Schoeler T; Monk A; Sami MB; Klamerus E; Foglia E; Brown R; Camuri G; Altamura AC; Murray R; Bhattacharyya S
Lancet Psychiatry; 2016 Mar; 3(3):215-25. PubMed ID: 26777297
[TBL] [Abstract][Full Text] [Related]
2. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.
Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
Lancet Psychiatry; 2017 Aug; 4(8):627-633. PubMed ID: 28705600
[TBL] [Abstract][Full Text] [Related]
3. Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.
Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Ajnakina O; Gayer-Anderson C; Colizzi M; Quattrone D; Behlke I; Shetty S; McGuire P; David AS; Murray R; Bhattacharyya S
Lancet Psychiatry; 2016 Oct; 3(10):947-953. PubMed ID: 27567467
[TBL] [Abstract][Full Text] [Related]
4. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
van der Meer FJ; Velthorst E;
Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Cannabis as a risk factor for psychosis: systematic review.
Semple DM; McIntosh AM; Lawrie SM
J Psychopharmacol; 2005 Mar; 19(2):187-94. PubMed ID: 15871146
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review.
Reid S; Bhattacharyya S
Psychiatry Res; 2019 Oct; 280():112523. PubMed ID: 31450032
[TBL] [Abstract][Full Text] [Related]
8. Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis.
Kraan T; Velthorst E; Koenders L; Zwaart K; Ising HK; van den Berg D; de Haan L; van der Gaag M
Psychol Med; 2016 Mar; 46(4):673-81. PubMed ID: 26568030
[TBL] [Abstract][Full Text] [Related]
9. Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
Ringen PA; Nesvåg R; Helle S; Lagerberg TV; Lange EH; Løberg EM; Agartz I; Andreassen OA; Melle I
Psychol Med; 2016 Nov; 46(15):3127-3136. PubMed ID: 27534999
[TBL] [Abstract][Full Text] [Related]
10. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.
Stone JM; Fisher HL; Major B; Chisholm B; Woolley J; Lawrence J; Rahaman N; Joyce J; Hinton M; Johnson S; Young AH;
Psychol Med; 2014 Feb; 44(3):499-506. PubMed ID: 23701858
[TBL] [Abstract][Full Text] [Related]
11. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.
Johnson S; Rains LS; Marwaha S; Strang J; Craig T; Weaver T; McCrone P; King M; Fowler D; Pilling S; Marston L; Omar RZ; Craig M; Spencer J; Hinton M
Health Technol Assess; 2019 Aug; 23(45):1-108. PubMed ID: 31460865
[TBL] [Abstract][Full Text] [Related]
12. Does change in cannabis use in established psychosis affect clinical outcome?
Barrowclough C; Emsley R; Eisner E; Beardmore R; Wykes T
Schizophr Bull; 2013 Mar; 39(2):339-48. PubMed ID: 22037770
[TBL] [Abstract][Full Text] [Related]
13. Effect of high-potency cannabis on corpus callosum microstructure.
Rigucci S; Marques TR; Di Forti M; Taylor H; Dell'Acqua F; Mondelli V; Bonaccorso S; Simmons A; David AS; Girardi P; Pariante CM; Murray RM; Dazzan P
Psychol Med; 2016 Mar; 46(4):841-54. PubMed ID: 26610039
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Changes in Cannabis Exposure on Psychotic Symptoms in Patients With Comorbid Cannabis Use Disorder.
Toftdahl NG; Nordentoft M; Hjorthøj C
J Dual Diagn; 2016; 12(2):129-36. PubMed ID: 27070732
[TBL] [Abstract][Full Text] [Related]
15. Cannabis use and psychosis: a review of reviews.
Hasan A; von Keller R; Friemel CM; Hall W; Schneider M; Koethe D; Leweke FM; Strube W; Hoch E
Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):403-412. PubMed ID: 31563981
[TBL] [Abstract][Full Text] [Related]
16. The impact of cannabis use on clinical outcomes in recent onset psychosis.
Barrowclough C; Gregg L; Lobban F; Bucci S; Emsley R
Schizophr Bull; 2015 Mar; 41(2):382-90. PubMed ID: 25011381
[TBL] [Abstract][Full Text] [Related]
17. Cannabis use in first episode psychosis: Meta-analysis of prevalence, and the time course of initiation and continued use.
Myles H; Myles N; Large M
Aust N Z J Psychiatry; 2016 Mar; 50(3):208-19. PubMed ID: 26286531
[TBL] [Abstract][Full Text] [Related]
18. Reasons and subjective effects of cannabis use among people with psychotic disorders: a systematic review.
Gómez Pérez L; Santacana AM; Bergé Baquero D; Pérez-Solá V
Actas Esp Psiquiatr; 2014; 42(2):83-90. PubMed ID: 24715366
[TBL] [Abstract][Full Text] [Related]
19. Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial.
Clausen L; Hjorthøj CR; Thorup A; Jeppesen P; Petersen L; Bertelsen M; Nordentoft M
Psychol Med; 2014 Jan; 44(1):117-26. PubMed ID: 23590927
[TBL] [Abstract][Full Text] [Related]
20. Adolescent Initiation of Cannabis Use and Early-Onset Psychosis.
Bagot KS; Milin R; Kaminer Y
Subst Abus; 2015; 36(4):524-33. PubMed ID: 25774457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
